Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. [electronic resource]
Producer: 20100604Description: 983-90 p. digitalISSN:- 1791-2423
- Adult
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis
- Cell Cycle
- Cell Proliferation
- Cells, Cultured
- Codon, Nonsense
- Codon, Terminator
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- DNA Damage
- Etoposide -- pharmacology
- Female
- Fibroblasts -- drug effects
- Genotype
- Germ-Line Mutation
- Heterozygote
- Humans
- Li-Fraumeni Syndrome -- genetics
- Male
- Middle Aged
- Pedigree
- Phenotype
- Polymorphism, Genetic
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.